Sign in

CIK 0001907108

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
854012572
Phone
+1 212-547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-24 Bhalla Narinder Pal Chief Medical Officer Grant or award · Stock Option (right to buy) +54,750 54,750
2026-09-24 Tamayo Louis Edward Chief Financial Officer Grant or award · Stock Option (right to buy) +54,750 54,750
2026-09-24 Otero Jose Manuel Chief Operating Officer Grant or award · Stock Option (right to buy) +54,750 54,750
2026-09-24 Townsend Richard Nolan Chief Executive Officer Grant or award · Stock Option (right to buy) +145,500 145,500
2026-09-14 Bhalla Narinder Pal Chief Medical Officer Grant or award +2,714 $3.58 $10K 84,908
2026-09-14 Otero Jose Manuel Chief Operating Officer Grant or award +2,110 $2.64 $6K 138,288
2026-09-14 Townsend Richard Nolan Chief Executive Officer Grant or award +2,306 $2.64 $6K 376,778
2026-08-18 Tamayo Louis Edward Chief Financial Officer Sale −4,117 $4.91 $20K 92,907
2026-08-18 Otero Jose Manuel Chief Operating Officer Sale −1,304 $4.96 $6K 136,178
2026-08-18 Townsend Richard Nolan Chief Executive Officer Sale −3,345 $4.95 $17K 374,472
2026-07-01 Bhalla Narinder Pal Chief Medical Officer Sale −22,306 $4.42 $99K 82,194
2026-07-01 Tamayo Louis Edward Chief Financial Officer Sale −4,641 $4.49 $21K 97,024
2026-07-01 Otero Jose Manuel Chief Operating Officer Sale −4,666 $4.48 $21K 137,482
2026-07-01 Townsend Richard Nolan Chief Executive Officer Sale −25,947 $4.48 $116K 377,817
2026-06-29 Bhalla Narinder Pal Chief Medical Officer Grant or award +55,000 104,500
2026-06-29 Tamayo Louis Edward Chief Financial Officer Grant or award +12,000 101,665
2026-06-29 Otero Jose Manuel Chief Operating Officer Grant or award +12,060 142,148
2026-06-29 Townsend Richard Nolan Chief Executive Officer Grant or award +67,000 403,764
2026-06-25 COOPERSTONE BRENDA Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-06-25 Tanguler Tolga Director Grant or award · Stock Option (right to buy) +35,000 35,000

Page 1 of 9 · 165 trades